$MGNI
Magnite Inc

2022 Q2 Form 10-Q Financial Statement

#000159597422000027 Filed on May 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $137.8M $118.1M $161.3M
YoY Change 20.29% 94.47% 96.68%
Cost Of Revenue $65.00M $59.40M $66.84M
YoY Change 28.65% 186.16% 215.75%
Gross Profit $72.78M $58.68M $94.45M
YoY Change 13.69% 46.85% 55.25%
Gross Profit Margin 52.82% 49.7% 58.56%
Selling, General & Admin $53.29M $68.70M $45.81M
YoY Change -11.56% 86.96% 21.4%
% of Gross Profit 73.22% 117.08% 48.5%
Research & Development $22.80M $23.04M $20.81M
YoY Change 25.91% 61.52% 46.24%
% of Gross Profit 31.33% 39.27% 22.03%
Depreciation & Amortization $46.16M $45.87M $49.80M
YoY Change 28.61% 267.37% 280.46%
% of Gross Profit 63.42% 78.16% 52.73%
Operating Expenses $95.39M $91.75M $90.41M
YoY Change 21.73% 79.85% 73.99%
Operating Profit -$22.61M -$39.82M $4.034M
YoY Change -51.87% 189.08% -49.54%
Interest Expense -$3.154M -$8.037M -$7.131M
YoY Change -37.48% 4923.13% 127.83%
% of Operating Profit -176.77%
Other Income/Expense, Net $1.359M -$6.774M $1.133M
YoY Change -134.79% -736.06% -158.13%
Pretax Income -$25.06M -$46.60M -$2.363M
YoY Change -50.76% 266.6% -139.08%
Income Tax -$104.0K -$2.000M -$2.816M
% Of Pretax Income
Net Earnings -$24.95M -$44.59M $453.0K
YoY Change -167.8% 246.3% -92.3%
Net Earnings / Revenue -18.11% -37.77% 0.28%
Basic Earnings Per Share -$0.19 -$0.34
Diluted Earnings Per Share -$188.4K -$0.34 $3.427K
COMMON SHARES
Basic Shares Outstanding 131.9M shares 132.2M shares 131.8M shares
Diluted Shares Outstanding 132.4M shares 132.2M shares

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $233.1M $204.6M $230.4M
YoY Change 20.81% -56.34% 95.75%
Cash & Equivalents $233.1M $204.6M $230.4M
Short-Term Investments
Other Short-Term Assets $22.60M $22.22M $19.93M
YoY Change -26.06% 27.7% 12.62%
Inventory
Prepaid Expenses
Receivables $886.1M $783.0M $927.8M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.142B $1.010B $1.178B
YoY Change 13.73% 13.74% 94.07%
LONG-TERM ASSETS
Property, Plant & Equipment $112.1M $34.99M $34.07M
YoY Change 225.58% 24.02% 43.86%
Goodwill $978.2M $969.9M
YoY Change 518.62% 513.38%
Intangibles $399.4M $426.6M
YoY Change 385.36% 374.63%
Long-Term Investments
YoY Change
Other Assets $7.169M $6.877M $6.862M
YoY Change 4.0% 63.08% 54.55%
Total Long-Term Assets $1.481B $1.513B $1.534B
YoY Change -3.68% 362.65% 362.35%
TOTAL ASSETS
Total Short-Term Assets $1.142B $1.010B $1.178B
Total Long-Term Assets $1.481B $1.513B $1.534B
Total Assets $2.622B $2.522B $2.713B
YoY Change 3.19% 107.66% 188.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $953.5M $838.7M $983.1M
YoY Change 16.27% 96.56% 97.85%
Accrued Expenses $39.08M $39.11M $36.97M
YoY Change -0.59% 116.08% 65.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.600M $3.600M $3.600M
YoY Change 0.0%
Total Short-Term Liabilities $1.002B $887.3M $1.029B
YoY Change 14.71% 97.64% 97.13%
LONG-TERM LIABILITIES
Long-Term Debt $721.4M $720.7M $720.0M
YoY Change 0.38% 85.44%
Other Long-Term Liabilities $65.97M $2.237M $2.647M
YoY Change 2211.35% -23.42% -0.94%
Total Long-Term Liabilities $787.4M $722.9M $722.7M
YoY Change 9.13% 84.63% 26946.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.002B $887.3M $1.029B
Total Long-Term Liabilities $787.4M $722.9M $722.7M
Total Liabilities $1.801B $1.685B $1.832B
YoY Change 8.92% 93.1% 228.67%
SHAREHOLDERS EQUITY
Retained Earnings -$439.0M -$394.5M
YoY Change 7.77% -0.02%
Common Stock $2.000K $2.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $6.007M
YoY Change
Treasury Stock Shares 0.000 shares 349.0K shares
Shareholders Equity $821.4M $837.9M $880.8M
YoY Change
Total Liabilities & Shareholders Equity $2.622B $2.522B $2.713B
YoY Change 3.19% 107.66% 188.9%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$24.95M -$44.59M $453.0K
YoY Change -167.8% 246.3% -92.3%
Depreciation, Depletion And Amortization $46.16M $45.87M $49.80M
YoY Change 28.61% 267.37% 280.46%
Cash From Operating Activities $42.32M $21.63M $68.59M
YoY Change 47.76% -1864.44% 473.01%
INVESTING ACTIVITIES
Capital Expenditures -$5.422M $7.184M -$6.618M
YoY Change -57.8% 445.48% -39.0%
Acquisitions $20.76M
YoY Change
Other Investing Activities $0.00 -$20.76M -$8.809M
YoY Change -100.0%
Cash From Investing Activities -$5.422M -$31.32M -$15.43M
YoY Change -99.15% 857.24% 42.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $12.14M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.180M -$16.39M -10.81M
YoY Change -102.16% -104.61% -201.69%
NET CHANGE
Cash From Operating Activities 42.32M $21.63M 68.59M
Cash From Investing Activities -5.422M -$31.32M -15.43M
Cash From Financing Activities -7.180M -$16.39M -10.81M
Net Change In Cash 29.72M -$25.81M 42.35M
YoY Change -110.79% -107.36% 260.44%
FREE CASH FLOW
Cash From Operating Activities $42.32M $21.63M $68.59M
Capital Expenditures -$5.422M $7.184M -$6.618M
Free Cash Flow $47.74M $14.45M $75.21M
YoY Change 15.07% -668.15% 229.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001595974
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-36384
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
MAGNITE, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8881738
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1250 Broadway,
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
15th Floor
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York,
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
CY2022Q1 dei City Area Code
CityAreaCode
212
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
243-2769
CY2022Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.00001 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
MGNI
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
131910148 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
204589000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
969873000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6877000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6862000 USD
CY2022Q1 us-gaap Assets
Assets
2522462000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
230401000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
782956000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
927781000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22219000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19934000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1009764000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1178116000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34986000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34067000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
72363000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
76986000 USD
CY2022Q1 mgni Internal Use Software Development Costs Net
InternalUseSoftwareDevelopmentCostsNet
20837000 USD
CY2021Q4 mgni Internal Use Software Development Costs Net
InternalUseSoftwareDevelopmentCostsNet
20093000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
399419000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
426615000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
978216000 USD
CY2021Q4 us-gaap Assets
Assets
2712612000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
859178000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1000956000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18638000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19142000 USD
CY2022Q1 us-gaap Debt Current
DebtCurrent
3600000 USD
CY2021Q4 us-gaap Debt Current
DebtCurrent
3600000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2237000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5903000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5697000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
887319000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1029395000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
720710000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
720023000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
11509000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
13303000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
62777000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
66487000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2647000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1684552000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
1831855000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132553000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132052000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132052000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132204000 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1278218000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1282589000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1266000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1376000 USD
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
349000 shares
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
0 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
6007000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-439044000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-394451000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
837910000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
880757000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2522462000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2712612000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118075000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60715000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
59396000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
20756000 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
50000000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22589000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23043000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14266000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18704000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14158000 USD
CY2022Q1 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
6756000 USD
CY2021Q1 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
2722000 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
157899000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
74491000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1065000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-39824000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13776000 USD
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7111000 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-143000 USD
CY2022Q1 us-gaap Other Operating Income
OtherOperatingIncome
1263000 USD
CY2021Q1 us-gaap Other Operating Income
OtherOperatingIncome
1223000 USD
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-926000 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-15000 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6774000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46598000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12711000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2005000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
166000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44593000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12877000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132236000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132236000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115296000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115296000 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44593000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12877000 USD
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
110000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-313000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
110000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-313000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44483000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13190000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
880757000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1107000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
381613000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5785000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7108000 USD
CY2021Q1 mgni Apic Share Based Payment Arrangement Decrease For Capped Calls
APICShareBasedPaymentArrangementDecreaseForCappedCalls
38960000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-313000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12877000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
342356000 USD
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4260000 USD
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
12138000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16927000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
110000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44593000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
837910000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44593000 USD
CY2021Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12877000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
45866000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12485000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
16589000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6993000 USD
CY2022Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3320000 USD
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-50000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-571000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-159000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1700000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
99000 USD
CY2022Q1 mgni Non Cash Lease Expense
NonCashLeaseExpense
610000 USD
CY2021Q1 mgni Non Cash Lease Expense
NonCashLeaseExpense
-652000 USD
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1891000 USD
CY2021Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1955000 USD
CY2021Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
62000 USD
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-458000 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
375000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-146241000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-70252000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2279000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1578000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-141312000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-80074000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2504000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1392000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21632000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1226000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7184000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1317000 USD
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
3382000 USD
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
20755000 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31321000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3272000 USD
CY2022Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2021Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
389000000 USD
CY2022Q1 mgni Payments For Capped Call Options
PaymentsForCappedCallOptions
0 USD
CY2021Q1 mgni Payments For Capped Call Options
PaymentsForCappedCallOptions
38960000 USD
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
198000 USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1107000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5785000 USD
CY2022Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
900000 USD
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
197000 USD
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 USD
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12138000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4260000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16388000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
355627000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-256000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25809000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
350873000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
230693000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117731000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
204884000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
468604000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
204589000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
468550000 USD
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
242000 USD
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
53000 USD
CY2021Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
54000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
204884000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
468604000 USD
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
338000 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
226000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
5668000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
51000 USD
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
372000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6050000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
338000 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
115000 USD
CY2022Q1 mgni Business Combination Consideration Transferred Indemnification Claims Holdback
BusinessCombinationConsiderationTransferredIndemnificationClaimsHoldback
2300000 USD
CY2021Q1 mgni Business Combination Consideration Transferred Indemnification Claims Holdback
BusinessCombinationConsiderationTransferredIndemnificationClaimsHoldback
0 USD
CY2022Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
CY2021Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
1349000 USD
CY2022Q1 mgni Debt Discount Received During Noncash Or Partial Noncash Transaction
DebtDiscountReceivedDuringNoncashOrPartialNoncashTransaction
0 USD
CY2021Q1 mgni Debt Discount Received During Noncash Or Partial Noncash Transaction
DebtDiscountReceivedDuringNoncashOrPartialNoncashTransaction
11000000 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported and disclosed financial statements and accompanying footnotes. Due to the economic uncertainty as a result of the COVID-19 pandemic, geopolitical events, including the conflict in Ukraine, and economic and macro-economic factors like labor shortages, supply chain disruptions, and inflation impacting the markets and communities in which our clients operate, it has become more difficult to apply certain assumptions and judgments into these estimates. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The extent of the impact of these factors on the Company's operational and financial performance will depend on future developments, which are highly uncertain and cannot be predicted, including but not limited to the duration and how quickly and to what extent normal economic and operating conditions can resume. During the three months ended March 31, 2022, this uncertainty continued to result in a higher level of judgment related to its estimates and assumptions. As of the date of issuance of the condensed consolidated financial statements for the three months ended March 31, 2022, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, judgments, or revise the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the consolidated financial statements as soon as they become known. Actual results could differ materially from these estimates.</span></div>
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-44593000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12877000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132236000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132236000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115296000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115296000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132236000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115296000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11422000 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13183000 shares
CY2022Q1 mgni Percent Of Revenue Gross Basis
PercentOfRevenueGrossBasis
0.03
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118075000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60715000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118075000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60715000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118075000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60715000 USD
CY2022Q1 mgni Revenue Payment Terms
RevenuePaymentTerms
P75D
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2100000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3500000 USD
CY2022Q1 mgni Accounts Payable Seller
AccountsPayableSeller
1200000 USD
CY2021Q4 mgni Accounts Payable Seller
AccountsPayableSeller
2100000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3475000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2360000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4000 USD
CY2022Q1 mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
-1466000 USD
CY2021Q1 mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
-877000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
87000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
20000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2096000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1499000 USD
CY2022Q1 mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
-1500000 USD
CY2022Q1 mgni Increase Decreasein Accounts Payable Seller
IncreaseDecreaseinAccountsPayableSeller
900000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-600000 USD
CY2021Q1 mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
-900000 USD
CY2021Q1 mgni Increase Decreasein Accounts Payable Seller
IncreaseDecreaseinAccountsPayableSeller
-700000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-200000 USD
CY2022Q1 mgni Accounts Payable Seller Current
AccountsPayableSellerCurrent
821848000 USD
CY2021Q4 mgni Accounts Payable Seller Current
AccountsPayableSellerCurrent
971220000 USD
CY2022Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
16857000 USD
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
11904000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16575000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16230000 USD
CY2022Q1 mgni Indemnification Claim Accrual Current
IndemnificationClaimAccrualCurrent
3898000 USD
CY2021Q4 mgni Indemnification Claim Accrual Current
IndemnificationClaimAccrualCurrent
1602000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
859178000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1000956000 USD
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
300000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
978200000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
969900000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
578908000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
571208000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
179489000 USD
CY2021Q2 us-gaap Share Price
SharePrice
49.21
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
144593000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
399419000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
426615000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38500000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7600000 USD
CY2022Q1 mgni Restructuring Impairments Settled Without Cash
RestructuringImpairmentsSettledWithoutCash
3300000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
111428000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
104924000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
87294000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
70647000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
24695000 USD
CY2022Q1 mgni Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
431000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
399419000 USD
CY2021Q2 us-gaap Share Price
SharePrice
40.05
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
775000 USD
CY2021Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2226000 USD
CY2022Q1 mgni Restructuring Reserve And Merger Related Costs Settled Without Cash
RestructuringReserveAndMergerRelatedCostsSettledWithoutCash
1944000 USD
CY2021Q1 mgni Restructuring Reserve And Merger Related Costs Settled Without Cash
RestructuringReserveAndMergerRelatedCostsSettledWithoutCash
377000 USD
CY2022Q1 mgni Restructuring Impairments Settled Without Cash
RestructuringImpairmentsSettledWithoutCash
3320000 USD
CY2021Q1 mgni Restructuring Impairments Settled Without Cash
RestructuringImpairmentsSettledWithoutCash
0 USD
CY2022Q1 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
6756000 USD
CY2021Q1 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
2722000 USD
CY2022Q1 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
6800000 USD
CY2021Q1 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
2700000 USD
CY2022Q1 mgni Restructuring Impairment Costs
RestructuringImpairmentCosts
3320000 USD
CY2022Q1 mgni Restructuring Impairments Settled Without Cash
RestructuringImpairmentsSettledWithoutCash
3320000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
13212745 shares
CY2022Q1 mgni Evergreen Annual Increase
EvergreenAnnualIncrease
0.05
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5129000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.25
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
699000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.90
CY2022Q1 mgni Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Gross
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodGross
311000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.56
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
21000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
15.24
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5496000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.27
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
35278000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3763000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.76
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
29168000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16589000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6993000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 USD
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
5600000 USD
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
3800000 USD
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
300000 USD
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
300000 USD
CY2022Q1 us-gaap Sublease Income
SubleaseIncome
1300000 USD
CY2021Q1 us-gaap Sublease Income
SubleaseIncome
1200000 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0515
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M24D
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
16397000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
19406000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
16593000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8783000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7761000 USD
CY2022Q1 mgni Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
27302000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
96242000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
14827000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
81415000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3600000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3600000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
720710000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
720023000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2700000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3600000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3600000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3600000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
403600000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
340200000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
757300000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1700000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
100000 USD
CY2021Q1 mgni Debt Instruments Capped Calls Transaction Costs
DebtInstrumentsCappedCallsTransactionCosts
39000000 USD
CY2021Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
11400000 USD
CY2021Q2 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
27700000 USD
CY2022Q1 mgni Amortization Of Debt Discount Premium Year Five
AmortizationOfDebtDiscountPremiumYearFive
1998000 USD
CY2022Q1 mgni Amortization Of Debt Issuance Costs Year Five
AmortizationOfDebtIssuanceCostsYearFive
3116000 USD

Files In Submission

Name View Source Status
0001595974-22-000027-index-headers.html Edgar Link pending
0001595974-22-000027-index.html Edgar Link pending
0001595974-22-000027.txt Edgar Link pending
0001595974-22-000027-xbrl.zip Edgar Link pending
exhibit311q12022.htm Edgar Link pending
exhibit312q12022.htm Edgar Link pending
exhibit32q12022.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mgni-20220331.htm Edgar Link pending
mgni-20220331.xsd Edgar Link pending
mgni-20220331_cal.xml Edgar Link unprocessable
mgni-20220331_def.xml Edgar Link unprocessable
mgni-20220331_htm.xml Edgar Link completed
mgni-20220331_lab.xml Edgar Link unprocessable
mgni-20220331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending